Ribbon Bio Named A Best Place to Work 2025 by GenomeWeb in 51-100 Employee Category

Recognition reflects company’s emphasis on inclusive culture across global operations and focus on professional growth and development VIENNA–(BUSINESS WIRE)–Ribbon Bio GmbH, the DNA synthesis company, has been named A Best Place to Work 2025 by GenomeWeb in the mid-size category of 51-100 employees. This recognition reflects Ribbon’s commitment to openness, inclusion and transparency, as well … [Read more…]

WELL Health Reports Strong Organic Growth, Major Advances in Clinic Digitization, and Rapid Progress on New Primary Care Patient Openings

WELL recently announced that it achieved quarterly revenue of over $110 million as part of its Canadian Patient Services business, reflecting growth of 41% on a YoY basis. WELL is pleased to provide enhanced disclosure on its organic growth metrics, including detailed breakdowns of same-clinic growth and absorption-driven organic growth. Overall same clinic revenue growth … [Read more…]

Yagi & Co., Ltd.: Exhibiting for the first time at ISPO Munich 2025, the world’s largest trade fair for sports goods, based in Germany

We propose textiles and products utilising original materials developed by our Materials Division specifically to address environmental, health, and heat countermeasures, primarily within the sports and outdoor sectors. TOKYO–(BUSINESS WIRE)–Yagi & Co., Ltd. (TOKYO:7460) (https://www.yaginet.co.jp/en/index.html) will be exhibiting for the first time at ISPO Munich, held in Munich, Germany, over three days from Sunday 30th … [Read more…]

Susannah Cantrell Joins Ossium Health as Chief Commercial Officer

SAN FRANCISCO–(BUSINESS WIRE)–Ossium Health, a bioengineering company dedicated to improving human health through its organ donor bone marrow banking platform, announced today that Dr. Susannah Cantrell, PhD, has joined its leadership team as Chief Commercial Officer (CCO). In her new role, Dr. Cantrell will be responsible for leading Ossium’s commercial strategy, go-to-market planning, and partnerships … [Read more…]

Agenus to Host End-of-Year Stakeholder Webcast Featuring GI Oncology Leaders and Progress of BOT/BAL

Webcast on Wednesday, December 3, 2025 at 4:00 p.m. ET LEXINGTON, Mass.–(BUSINESS WIRE)–$AGEN #BATTMAN—Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in immuno-oncology, today announced it will host its End-of-Year 2025 Stakeholder Webcast on Wednesday, December 3, 2025 at 4:00 p.m. ET. The session will feature leading experts in gastrointestinal oncology and patient advocates discussing progress … [Read more…]

Hercules Pharmaceuticals Announces Membership in the Healthcare Distribution Alliance and Board Appointment of Timothy Ward

NEW YORK–(BUSINESS WIRE)–Hercules Pharmaceuticals (Hercules), a national leader in pharmaceutical distribution and provider-aligned GPO services, today announced its membership in the Healthcare Distribution Alliance (HDA), the leading trade association representing pharmaceutical distributors in the United States. In connection with the announcement, Timothy Ward, Founder, President and Chief Legal Officer of Hercules, has been appointed to … [Read more…]

New Research from the Humana Foundation Examines Food Insecurity Crisis Among Kentucky Seniors

LOUISVILLE, Ky.–(BUSINESS WIRE)–The Humana Foundation, the philanthropic arm of Humana Inc. for the past 44 years, today announced the publication of its new issue brief, Senior Food Insecurity in Kentucky: A Growing Public Health Challenge. The brief examines the complex web of challenges the state’s older adults face in accessing nutritious foods and offers a … [Read more…]

Ryder & BJC Health System Secure SMI Collaboration Award for Transforming Healthcare Supply Chain, Enhancing Patient Care

Strategic Collaboration Delivers Near 100% Fulfillment Rates, 100% Real-Time Visibility, and Resilient Medical Logistics Across 14 Hospitals MIAMI–(BUSINESS WIRE)–#Collaboration—Ryder System, Inc. (NYSE: R) and BJC Health System, based in St. Louis, Missouri, secure the prestigious SMI Tom Hughes Collaboration Award for their transformative work in reshaping the healthcare supply chain to improve patient care and … [Read more…]

Biocentis secures $19M to revolutionize insect control through programmable biology

LONDON & MILAN–(BUSINESS WIRE)–#AI–Biocentis, a life-science company at the forefront of genetic innovation, has raised $19 million to advance its mission of protecting health, agriculture, and biodiversity from the growing global threats posed by insects. The financing includes a $13M seed equity investment led by the Grantham Foundation for the Protection of the Environment (US) … [Read more…]

YolTech Therapeutics Receives FDA IND Clearance to Initiate Global Pivotal Trial of In Vivo Gene-Editing Therapy YOLT-203 for Primary Hyperoxaluria Type 1 (PH1)

SHANGHAI–(BUSINESS WIRE)–YolTech Therapeutics, a clinical-stage biotechnology company developing next-generation in vivo gene editing therapies, today announced that the U.S. Food and Drug Administration (FDA) has cleared the company’s Investigational New Drug (IND) application for YOLT-203, an in vivo gene-editing therapy for the treatment of Primary Hyperoxaluria Type 1 (PH1). The global multicenter, randomized, double-blind, placebo-controlled … [Read more…]